144 related articles for article (PubMed ID: 34379542)
21. Regional variation in surgical assessment of lymph nodes for staging among women with early-stage epithelial ovarian cancer.
Ulanday KT; Ward KK; Macera CA; Ji M; Plaxe SC
Gynecol Oncol; 2014 Feb; 132(2):411-5. PubMed ID: 24246773
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of Transabdominal Cardiophrenic Lymphnode Dissection in Advanced Ovarian Cancer: Initial Experience at a Tertiary Center.
Garbi A; Zanagnolo V; Colombo N; Aletti G; Achilarre MT; Bocciolone L; Landoni F; Rizzo S; Biffi R; Maggioni A
Int J Gynecol Cancer; 2017 Jul; 27(6):1268-1273. PubMed ID: 28498236
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer.
Gouy S; Goetgheluck J; Uzan C; Duclos J; Duvillard P; Morice P
Eur J Surg Oncol; 2012 Feb; 38(2):170-5. PubMed ID: 22104389
[TBL] [Abstract][Full Text] [Related]
24. Metastasis to para-aortic lymph nodes cephalad to the renal veins in patients with ovarian cancer.
Komiyama S; Nagashima M; Taniguchi T; Rikitake T; Morita M
World J Surg Oncol; 2020 Apr; 18(1):64. PubMed ID: 32238145
[TBL] [Abstract][Full Text] [Related]
25. Thoracoscopic Resection of Fluorodeoxyglucose-Avid Mediastinal Lymph Nodes Associated with Advanced Ovarian Carcinoma.
Hamaji M; Yamaguchi K; Koyasu S; Date H
Thorac Cardiovasc Surg; 2019 Dec; 67(8):692-696. PubMed ID: 30086572
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
Song N; Gao Y
Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
[TBL] [Abstract][Full Text] [Related]
27. The impact of lymph node dissection on apparent Stage I epithelial ovarian carcinoma: A population-based study.
Chen Q; Wang S; Lang JH
Int J Gynaecol Obstet; 2021 Sep; 154(3):550-557. PubMed ID: 33507544
[TBL] [Abstract][Full Text] [Related]
28. Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma.
Takei Y; Takahashi S; Machida S; Taneichi A; Yoshiba T; Takahashi Y; Yoshida C; Saga Y; Matsubara S; Fujiwara H
Int J Clin Oncol; 2018 Oct; 23(5):930-935. PubMed ID: 29679177
[TBL] [Abstract][Full Text] [Related]
29. Pelvic lymph node dissection in early ovarian cancer: success of retrieval of lymph nodes by individual lymph node groups in respect to pelvic laterality.
Mujezinović F; Takac I
Eur J Obstet Gynecol Reprod Biol; 2010 Aug; 151(2):208-11. PubMed ID: 20457482
[TBL] [Abstract][Full Text] [Related]
30. The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer.
Deng T; Huang Q; Wan T; Luo X; Feng Y; Huang H; Liu J
J Gynecol Oncol; 2021 May; 32(3):e40. PubMed ID: 33825356
[TBL] [Abstract][Full Text] [Related]
31. What are the implications of radiologically abnormal cardiophrenic lymph nodes in advanced ovarian cancer? An analysis of tumour burden, surgical complexity, same-site recurrence and overall survival.
Addley S; Asher V; Kirke R; Bali A; Abdul S; Phillips A
Eur J Surg Oncol; 2022 Dec; 48(12):2531-2538. PubMed ID: 35718677
[TBL] [Abstract][Full Text] [Related]
32. Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literature.
Desteli GA; Gultekin M; Usubutun A; Yuce K; Ayhan A
World J Surg Oncol; 2010 Nov; 8():106. PubMed ID: 21114870
[TBL] [Abstract][Full Text] [Related]
33. Intraoperative Ultrasound-Guided Excision of Cardiophrenic Lymph Nodes in an Advanced Ovarian Cancer Patient.
Moro F; Uccella S; Testa AC; Scambia G; Fagotti A
Int J Gynecol Cancer; 2018 Nov; 28(9):1672-1675. PubMed ID: 30371564
[TBL] [Abstract][Full Text] [Related]
34. Predictive factors of lymph node metastasis and pattern of repartition in patients with epithelial ovarian cancer.
Atallah D; Arab W; Dagher B; Khalil N; El Rawadi E; Atallah B; Ghaname W; El Kassis N; Chahine G; Moubarak M
Future Oncol; 2021 Dec; 17(36):5093-5101. PubMed ID: 34821515
[No Abstract] [Full Text] [Related]
35. [Therapeutic value of lymphadenectomy in ovarian cancer patients].
Gmyrek L; Jońska-Gmyrek J; Żółciak-Siwińska A
Ginekol Pol; 2014 Oct; 85(10):788-91. PubMed ID: 25546932
[TBL] [Abstract][Full Text] [Related]
36. The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer.
Yavuzcan A; Baloglu A; Cetinkaya B
Arch Gynecol Obstet; 2009 Dec; 280(6):939-44. PubMed ID: 19306011
[TBL] [Abstract][Full Text] [Related]
37. Metastatic cardiophrenic lymph node resection following full-thickness resection of right diaphragm for advanced ovarian carcinoma.
Nishikimi K; Tate S; Matsuoka A; Shozu M
Gynecol Oncol; 2018 Sep; 150(3):581-583. PubMed ID: 30032929
[TBL] [Abstract][Full Text] [Related]
38. Lymph node-positive stage IIIC ovarian cancer: a separate entity?
Berek JS
Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S18-20. PubMed ID: 19955908
[TBL] [Abstract][Full Text] [Related]
39. What can we learn from the 10 mm lymph node size cut-off on the CT in advanced ovarian cancer at the time of interval debulking surgery?
Benoit L; Zerbib J; Koual M; Nguyen-Xuan HT; Delanoy N; Le Frère-Belda MA; Bentivegna E; Bats AS; Fournier L; Azaïs H
Gynecol Oncol; 2021 Sep; 162(3):667-673. PubMed ID: 34217542
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer.
Ataseven B; Grimm C; Harter P; Prader S; Traut A; Heitz F; du Bois A
Gynecol Oncol; 2014 Dec; 135(3):435-40. PubMed ID: 25312398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
